{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T21:44:56Z","timestamp":1790113496393,"version":"4.0.1"},"reference-count":32,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1016\/j.ejpb.2012.01.004","type":"journal-article","created":{"date-parts":[[2012,1,16]],"date-time":"2012-01-16T01:47:27Z","timestamp":1326678447000},"page":"91-101","source":"Crossref","is-referenced-by-count":97,"title":["Layered inorganic nanocomposites: A promising carrier for 5-fluorouracil (5-FU)"],"prefix":"10.1016","volume":"81","author":[{"given":"Bhavesh D.","family":"Kevadiya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tapan A.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devendrasinh D.","family":"Jhala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul P.","family":"Thumbar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harshad","family":"Brahmbhatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maharshi P.","family":"Pandya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shalini","family":"Rajkumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prasant K.","family":"Jena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghanshyam V.","family":"Joshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pankaj K.","family":"Gadhia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.B.","family":"Tripathi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hari C.","family":"Bajaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2012.01.004_b0005","first-page":"143","article-title":"A gastro-retentive floating delivery system for 5-fluorouracil","volume":"2","author":"Gupta","year":"2007","journal-title":"Asian J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2012.01.004_b0010","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/nrd1414","article-title":"Targeted therapy for brain tumours","volume":"3","author":"Lesniak","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejpb.2012.01.004_b0015","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0378-5173(02)00172-2","article-title":"5-Fluorouracil encapsulated alginate beads for the treatment of breast cancer","volume":"242","author":"Ar\u0131ca","year":"2002","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2012.01.004_b0020","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/jbm.10156","article-title":"Membrane-encased polymer millirods for sustained release of 5-fluorouracil","volume":"61","author":"Qian","year":"2002","journal-title":"J. Biomed. Mater. Res."},{"key":"10.1016\/j.ejpb.2012.01.004_b0025","first-page":"14","article-title":"In vitro anticancer evaluation of 5-fluorouracil lipid nanoparticles using B16F10 melanoma cell Lines","volume":"2","author":"Shenoy","year":"2012","journal-title":"Int. Nano Lett."},{"key":"10.1016\/j.ejpb.2012.01.004_b0030","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S0039-6109(03)00225-1","article-title":"Regional chemotherapeutic techniques for liver tumors: current knowledge and future directions","volume":"84","author":"Elias","year":"2004","journal-title":"Surg. Clin. North Am."},{"key":"10.1016\/j.ejpb.2012.01.004_b0035","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1186\/1471-2407-10-402","article-title":"5-FU-hydrogel inhibits colorectal peritoneal carcinomatosis and tumor growth in mice","volume":"10","author":"Wang","year":"2010","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ejpb.2012.01.004_b0040","doi-asserted-by":"crossref","first-page":"763","DOI":"10.2147\/IJN.S12415","article-title":"Preparation of 5-fluorouracil nanoparticles by supercritical antisolvents for pulmonary delivery","volume":"5","author":"Kalantarian","year":"2010","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.ejpb.2012.01.004_b0045","doi-asserted-by":"crossref","first-page":"873","DOI":"10.5012\/bkcs.2011.32.3.873","article-title":"A blood-brain barrier permeable derivative of 5-fluorouracil: preparation, intracellular localization, and mouse tissue distribution","volume":"32","author":"Jungkyun","year":"2011","journal-title":"Bull. Korean Chem. Soc."},{"key":"10.1016\/j.ejpb.2012.01.004_b0050","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nrc1074","article-title":"5-Fluorouracil: mechanisms of action and clinical strategies","volume":"3","author":"Longley","year":"2003","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ejpb.2012.01.004_b0055","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1093\/annonc\/mdh264","article-title":"5-Fluorouracil incorporation into RNA and DNA in relation to thymidylate synthase inhibition of human colorectal cancers","volume":"15","author":"Noordhuis","year":"2004","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.ejpb.2012.01.004_b0060","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/nrclinonc.2009.165","article-title":"Liver metastases from colorectal cancer: radioembolization with systemic therapy","volume":"6","author":"Nicolay","year":"2009","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"11","key":"10.1016\/j.ejpb.2012.01.004_b0065","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1200\/JCO.1994.12.11.2239","article-title":"Dihydropyrimidine dehydrogenase activity and fluorouracil chemotherapy","volume":"12","author":"Diasio","year":"1994","journal-title":"J. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.ejpb.2012.01.004_b0070","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1002\/(SICI)1097-0142(19960201)77:3<441::AID-CNCR4>3.0.CO;2-N","article-title":"Relationship between 5-fluorouracil (5-FU) dose intensity and therapeutic response in patients with advanced colorectal cancer receiving infusional therapy containing 5-FU","volume":"77","author":"Gamelin","year":"1996","journal-title":"Cancer"},{"issue":"7","key":"10.1016\/j.ejpb.2012.01.004_b0075","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1023\/A:1008282824860","article-title":"Randomized trial comparing monthly low-dose leucovorin and fluorouracil bolus with weekly high-dose 48-hour continuous-infusion fluorouracil for advanced colorectal cancer: a Spanish Cooperative Group for Gastrointestinal Tumor Therapy (TTD) study","volume":"9","author":"Aranda","year":"1998","journal-title":"Ann. Oncol."},{"issue":"4","key":"10.1016\/j.ejpb.2012.01.004_b0080","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1200\/JCO.1998.16.4.1450","article-title":"3rd Phase I clinical and pharmacologic study of eniluracil plus fluorouracil in patients with advanced cancer","volume":"16","author":"Schilsky","year":"1998","journal-title":"J. Clin. Oncol."},{"issue":"103","key":"10.1016\/j.ejpb.2012.01.004_b0085","first-page":"1","article-title":"Pharmacokinetic characteristics and anticancer effects of 5-fluorouracil loaded nanoparticles","volume":"8","author":"Li","year":"2008","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ejpb.2012.01.004_b0090","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.ijpharm.2010.01.002","article-title":"Layered bionanocomposites as carrier for procainamide","volume":"388","author":"Kevadiya","year":"2010","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2012.01.004_b0095","doi-asserted-by":"crossref","first-page":"6068","DOI":"10.1016\/j.biomaterials.2005.03.021","article-title":"Poly (d,l-lactide-co-glycolide)\/montmorillonite nanoparticles for oral delivery of anticancer drugs","volume":"26","author":"Dong","year":"2005","journal-title":"Biomaterials"},{"key":"10.1016\/j.ejpb.2012.01.004_b0100","doi-asserted-by":"crossref","first-page":"3206","DOI":"10.1016\/j.biomaterials.2009.02.045","article-title":"Poly(lactide)-vitamin E derivative\/montmorillonite nanoparticle formulations for the oral delivery of docetaxel","volume":"30","author":"Feng","year":"2009","journal-title":"Biomaterials"},{"key":"10.1016\/j.ejpb.2012.01.004_b0105","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1016\/S0142-9612(01)00325-8","article-title":"A study of purified montmorillonite intercalated with 5-fluorouracil as drug carrier","volume":"23","author":"Lin","year":"2002","journal-title":"Biomaterials"},{"key":"10.1016\/j.ejpb.2012.01.004_b0160","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0378-5173(83)90064-9","article-title":"Mechanisms of solute release from porous hydrophilic polymers","volume":"15","author":"Korsmeyer","year":"1983","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2012.01.004_b0110","doi-asserted-by":"crossref","first-page":"333","DOI":"10.3109\/10520296509116440","article-title":"Leukocytes cultured from small inoculum of whole blood and the preparation of chromosomes by treatment with hypotonic KCI","volume":"40","author":"Hungerford","year":"1965","journal-title":"Stain. Technol."},{"key":"10.1016\/j.ejpb.2012.01.004_b0115","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/0014-4827(88)90265-0","article-title":"A simple technique for quantitation of low levels of damage in individual cells","volume":"175","author":"Singh","year":"1988","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.ejpb.2012.01.004_b0120","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0921-8777(96)00047-X","article-title":"Study of DNA damage induction and repair capacity of fresh and cryopreserved lymphocytes, exposed to H2O2 and \u03b3-irradiation, with the alkaline comet assay","volume":"383","author":"Visvardis","year":"1997","journal-title":"Mut. Res."},{"key":"10.1016\/j.ejpb.2012.01.004_b0125","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1211\/jpp.60.5.0007","article-title":"In-vivo evaluation in rats of colon-specific microspheres containing 5-fluorouracil","volume":"60","author":"Rahman","year":"2008","journal-title":"J. Pharm. Pharm."},{"key":"10.1016\/j.ejpb.2012.01.004_b0130","doi-asserted-by":"crossref","first-page":"3774","DOI":"10.1021\/cm0343047","article-title":"Biopolymer\u2013clay nanocomposites based on chitosan intercalated in montmorillonite","volume":"15","author":"Darder","year":"2003","journal-title":"Chem. Mater."},{"key":"10.1016\/j.ejpb.2012.01.004_b0135","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1039\/b914548f","article-title":"Bionanocomposites formed by in situ charged chitosan with clay","volume":"11","author":"Shchipunov","year":"2009","journal-title":"Green Chem."},{"issue":"3","key":"10.1016\/j.ejpb.2012.01.004_b0140","first-page":"583","article-title":"Iontophoresis of 5-fluorourocil into the conjunctiva and sclera","volume":"30","author":"Kondo","year":"1989","journal-title":"Invest. Ophthal. Vis. Sci."},{"key":"10.1016\/j.ejpb.2012.01.004_b0145","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ijpharm.2005.04.004","article-title":"Effects of ionization and penetration enhancers on the transdermal delivery of 5-fluorouracil through excised human stratum corneum","volume":"298","author":"Singh","year":"2005","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2012.01.004_b0150","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ijpharm.2009.03.004","article-title":"Montmorillonite as a drug delivery system: intercalation and in vitro release of timolol maleate","volume":"374","author":"Joshi","year":"2009","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2012.01.004_b0155","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1016\/j.actbio.2009.08.027","article-title":"Controlled and extended drug release behavior of chitosan-based nanoparticle carrier","volume":"6","author":"Yuan","year":"2010","journal-title":"Acta Biomater."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641112000057?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641112000057?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,26]],"date-time":"2018-11-26T21:27:11Z","timestamp":1543267631000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641112000057"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["S0939641112000057"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2012.01.004","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2012,5]]}}}